Last reviewed · How we verify
NCT05837923
Radicle Relief 2: A Study of Health and Wellness Products on Pain and Health Outcomes
NA trial testing Relief Active Study Product 1.1 Usage in Pain in 2,016 participants. Completed in 17 July 2024.
17 July 2024
Quick facts
| Lead sponsor | Radicle Science |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 2,016 |
| Start date | 28 May 2024 |
| Primary completion | 17 July 2024 |
| Estimated completion | 17 July 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Relief Active Study Product 1.1 Usage
- Relief Active Study Product 1.2 Usage
- Placebo Control Form 1
- Relief Active Study Product 2.1 Usage
- Placebo Control Form 2
- Placebo Control Form 3
- Relief Active Study Product 3.1 Usage
- Relief Active Study Product 3.2 Usage
- Relief Active Study Product 3.3 Usage
Conditions studied
- Pain — all drugs for Pain →
- Neuropathic Pain — all drugs for Neuropathic Pain →
- Nociceptive Pain — all drugs for Nociceptive Pain →
Sponsor
Radicle Science — full company profile →
Who can join
Adults 21 to 105, any sex, with Pain or Neuropathic Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomized, blinded, placebo-controlled study assessing the impact of health and wellness products on pain and other health outcomes
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05837923
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pain
Currently open trials in the same condition.
- NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
- NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting
Other Radicle Science trials
Trials by the same sponsor.
- NCT07435350 — A Trial to Assess the Pharmacokinetics and Pharmacodynamics of a Novel Synbiotic Oral Supplement for Vaginal Health · NA · not yet recruiting
- NCT07386964 — Radicle Clarity CNM™: A Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Hea · NA · not yet recruiting
- NCT07342192 — Radicle Clarity DSTTM: A Study Assessing the Impact of Health and Wellness Products on Mental Clarity and Related Health · NA · not yet recruiting
- NCT07318077 — Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outc · NA · recruiting
- NCT07262775 — Radicle Relief RAL™: A Study Assessing the Impact of Health and Wellness Products on Pain Relief and Related Health Outc · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05837923 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Radicle Science
- Last refreshed: 6 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05837923.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing